stimulate IFN production in these lines. A third T-lymphoblastoid line, CCRF/ HSB2, produced no IFN either spontaneously or after infection with Sendai virus or treatment with phytohemagglutinin. The Molt 4 cells contained an mRNA which could be translated by oocytes to give IFN-y. Molt 4 cells therefore provide a convenient source of human IFN--y and its mRNA for experimental purposes.
The interferons (IFNs) which have been characterized to date fall into three classes, a, ,B, and -y, corresponding to the types previously known as leukocyte, fibroblast, and immune (4) , which may be distinguished by antigenic or sequence criteria. Of these three types, IFN-a and -P are relatively easily produced in large amounts by treatment of leukocyte cultures or cell lines with viruses or double-stranded RNA or, more recently, by genetic engineering techniques. However, IFN--y is not so easily made: the only presently available method for IFN-y production is the treatment of leukocyte cultures with T-cell mitogens. The T-lymphocytes in these cultures generate variable and usually small amounts of IFN-,y, which is contaminated with other lymphokines, sometimes with other IFN types (5) , and always with the inducing mitogen. A human cell line capable of producing IFN-y would obviously provide a convenient source for experimental studies (15) . We have therefore examined three T-lymphoblastoid cell lines, Molt 4, CCRF/CEM, and CCRF/HSB2. Molt 4 and CCRF/CEM lines produce IFN-1 upon virus induction, whereas CCRF/HSB2 does not produce detectable levels of IFN. Molt 4, but not the other two lines, spontaneously produces an acid-labile IFN which is not neutralized by antisera to IFN-a or -P and is therefore putatively IFN--y. The T-cell mitogen phytohemmagglutinin has no effect on IFN production by the three lines. MATERIALS (13) . Ten oocytes, injected with 30-nl aliquots of the same mRNA (5 mg/ml) were incubated for 24 h in 400 ,ul of modified Barth-X medium before the interferon secreted into the medium was assayed (3). Some RNA preparations were chromatographed over oligodeoxythymidylic acid-cellulose before injection into oocytes of a 1-mg/ml solution (13) .
Chemicals These experiments indicate that the antiviral activity is due to an IFN as defined by the Committee on Nomenclature (4).
The IFN spontaneously produced by the Molt 4 cells induced two enzymes in HFF cells which are known to be induced by IFN-y produced by mitogen-stimulated leukocytes (8) . These enzymes were a protein kinase (molecular weight, 67,000), identified by its mobility on polyacrylamide gels, and pppA(2'p5'A)n synthetase, identified by its enzymatic activity (data not shown). This further confirms that the Molt 4 material is an IFN.
As yet no anti--y serum is available; thus, IFN--y is defined as an IFN that is not neutralized by anti-a or anti-, serum. The IFN produced spontaneously by Molt 4 cells was shown not to be neutralized by antisera to IFN-a or -P and is thus IFN--y ( Fig. 1 ). Addition to the Molt 4 cultures of butyrate or 5'-bromo-3'-deoxyuridine, which are known to stimulate IFN-a production (14, 17) , either had no effect or led to a reduction of IFN yields. Chromatographic properties of IFN-,y from Molt 4 cells. Large amounts of IFN-y were prepared from Molt 4 cells cultured as described above so that purification could be attempted. The IFN--y was concentrated 30-fold by ultrafiltration, yielding preparations with titers of about 104. Addition of ammonium sulfate to 40% saturation did not precipitate the IFN. Both crude and concentrated preparations were subjected to chromatography, using a number of affinity chromatography materials known to bind mouse or human IFN-y. These were Cibacron BlueSepharose CL-6B (12, 18) , polyuridylic acidSepharose CL-6B (12, 19) , concanavalin A-Sepharose (12, 18) , phenyl-Sepharose CL-6B (12, 18) , Affigel 202 (18) , and controlled-pore glass (5, 10, 19) . The IFN bound only to concanavalin A-Sepharose, suggesting that it contains carbohydrate. The lack of binding of Molt 4 IFN-y to ligands known to bind IFN-y derived from mitogen-induced leukocytes again indicates that the two IFN types may not be identical.
Presence of mRNA coding for IFN-'y in Molt 4 cells. Since Molt 4 cells produce IFN--y constitutively, mRNA coding for IFN should also be The IFN produced by translation of RNA from Molt 4 cells in oocytes was compared with that synthesized by Molt 4 cells. In both cases the antiviral activity was not neutralized by antiserum directed against IFN-a or -P, whereas the activity was completely destroyed by pH 2 treatment. Thus, the RNA from Molt 4 cells is coding for an IFN that is neither a nor ,B but y.
RNA was extracted from growing cultures of Molt 4 cells to test whether the IFN levels correlated with the levels of IFN in the medium. Figure 1 shows that this was not the case; instead, the levels of IFN mRNA remained fairly constant. Thus, the IFN mRNA seems to be present constitutively in a fixed amount. principal IFN produced when B-lymphoblastoid cells are infected with a virus is a, with at least some lines producing 1 also (e.g., Namalwa [7] ). We find that two human T-lymphoblastoid lines, Molt 4 and CCRF/CEF, produce mostly or entirely IFN-,B upon virus infection. This confirms the previous observation of Larssen et al. (9) . Constitutive production of mouse IFN--y by a mouse lymphoblastoid cell line has been reported by Ponzio et al. (15) . We have now found that a human T-lymphoblastoid line constitutively produces an IFN which conforms to the definition of IFN--y as laid down by the Committee on Nomenclature (4). This line will obviously provide a convenient source of IFN-y for laboratory studies, yielding up to 300 U/ml by simple manipulation of culture conditions. We are currently investigating methods of further increasing yields. Preliminary efforts to purify the IFN have been unsuccessful, but a 30-fold concentration can easily be achieved by ultrafiltration to yield preparations with titers of 104. The IFN--y from these cells is mitogen-free and essentially uncontaminated with IFN-a or -13, although there may be other lymphokines present.
We do not know the exact relationship between IFN-y from Molt 4 and mitogen-induced IFN--y from leukocytes. The differences in titration and affinity chromatography properties of the two suggest that they are not identical; however, these differences may be trivial. We have also demonstrated the mRNA for IFN--y in Molt 4 cells. This mRNA is constitutively present, and the amounts do not seem to vary with changes in culture conditions. The finding that the IFN produced by oocyte translation of this mRNA is plainly y indicates that the mRNA for -y is distinct from that for IFN-a or -1; that is, IFN--y is not a post-translationally modified polypeptide translated from the IFN-a or -, mRNA. The constitutive production of IFN by a cell line raises interesting questions concerning the response of the cell line to IFN: Molt 4 cells have been shown to be sensitive to the cell growth inhibitory properties of IFN (2) . Thus, it should be expected that the cells are permanently in the antiviral state and are presumably relatively resistant to the anticell growth effect of IFN. We are currently investigating these questions.
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